Search
Clinical Trials
Life Molecular LMT-01-01-22
A Phase 3 Double-blind, Randomized, Placebo-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of AR1001 over 52 Weeks in Participants with Early Alzheimer’s Disease
New IDEAS: Imaging Dementia—Evidence for Amyloid Scanning Study
ENVISION
TRAILBLAZER-ALZ 3
Research Studies
Featured Investigator
Sylvia Sudat
PhD
Dr. Sudat is a Sutter Health Epic data and analytic expert, and an informal content leader for the analytics team at Sutter’s Center for Health Systems Research